BamSEC and AlphaSense Join Forces
Learn More

Athira Pharma Inc.

NASDAQ: ATHA    
Share price (8/14/25): $0.40    
Market cap (8/14/25): $15.7 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-3 48 pages Athira Pharma, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.3
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4
from 10-K 7 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from S-3 53 pages Athira Pharma, Inc. Indenture Dated as of [ ], 202_ [ ] Trustee
12/34/56
EX-4.3
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.6
from S-1/A 10 pages Warrant to Purchase Common Stock of Athira Pharma, Inc. Date of Issuance: 26 August 2020
12/34/56
EX-4.5
from S-1/A 10 pages Warrant to Purchase Common Stock of M3 Biotechnology, Inc. Date of Issuance: 08 April 2013
12/34/56
EX-4.2
from S-1/A 160 pages Athira Pharma, Inc. Investors’ Rights Agreement May 29, 2020
12/34/56
EX-4.4
from S-1 23 pages Warrant to Purchase Shares of Common Stock of Athira Pharma, Inc. Dated as of [ ], 2020 Void After the Date Specified in Section 8
12/34/56
EX-4.3
from S-1 21 pages Warrant to Purchase Shares of Series B Preferred Stock of Athira Pharma, Inc. Dated as of May 29, 2020 Void After the Date Specified in Section 8
12/34/56